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edition of Cancer Medicine attempts to
summarize the theoretical background and
practical management of cancer in almost
2500 pages, contributed by no less than 185
authors.
The presentation is similar to the first
edition, with many of the same contributors
updating their sections. New authors and
sections have been added on subjects as
diverse as computerized tomography and
psychologicalproblems of cancer. The section
on selected new developments has been
greatly expanded to provide chapter by
chapterupdates ofinformation current to the
middle of 1981.
Like all multiple author textbooks, the
standard of contribution varies, but the
overall standard is very high. This second
edition I feel sure will continue the success of
the first edition as an authoritative standard
text ofMedical Oncology.
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Multiple myeloma is a relatively common
haematological malignancy, but since its
discovery in the mid-1800's has engendered
substantial clinical and laboratory study.
However myeloma at the clinical level
remains a complex and unsolved problem.
Sydney Salmon as guest editor ofthis issue of
Clinics in Haematology has brought together
a talented group of workers to review the
clinically relevant areas of research, current
treatment, and future prospects.
Disorders related to myeloma, such as
amyloidosis, and monoclonal gammopathies
of undetermined significance are clearly
reviewed by Professor Kyle of the Mayo
Clinic. Salmon and Durie review their
research work on in vitro cloning ofmyeloma
stem cells, kinetic studies, and staging of
multiplemyeloma, as well as patient manage-
ment in a series of well written chapters.
Barlogie and co-workers discuss their experi-
ence using flow cytometry techniques in
myeloma research. Other chapters review the
immunoregulatory circuits found inmyeloma,
surface marker studies oncirculatinglympho-
cytes, localized plasmacytomas, interferon
treatment, and association ofacute leukaemia
withmyeloma.
This latest edition of Clinics in Haematol-
ogy maintains the high standards we have
come to expect from the series. Physicians
and research workers interested in multiple
myeloma will find this a fascinating and
informative review.
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